Improved survival with rituximab-based chemoimmunotherapy in older patients with extranodal diffuse large B-cell lymphoma. [electronic resource]
Producer: 20140924Description: 866-73 p. digitalISSN:- 1873-5835
- Aged
- Aged, 80 and over
- Antibodies, Monoclonal, Murine-Derived -- administration & dosage
- Antineoplastic Combined Chemotherapy Protocols -- therapeutic use
- Cyclophosphamide -- therapeutic use
- Doxorubicin -- therapeutic use
- Female
- Humans
- Immunotherapy -- methods
- Lymphoma, Large B-Cell, Diffuse -- drug therapy
- Male
- Medicare
- Prednisone -- therapeutic use
- Retrospective Studies
- Rituximab
- SEER Program
- Survival Analysis
- United States -- epidemiology
- Vincristine -- therapeutic use
No physical items for this record
Publication Type: Journal Article; Research Support, U.S. Gov't, P.H.S.
There are no comments on this title.
Log in to your account to post a comment.